Sanofi

In our moments of self-doubt, it’s the people who believe in us that pick us back up. 🙌 For Arnaud DOURLENS, our first torchbearer for the Olympic Games Paris 2024, that person is his former manager, Catherine Lentgen, Head of Procurement for Consumer Healthcare. It was no surprise to Catherine that Arnaud was chosen for this once-in-a-lifetime role because, in the spirit of a true Sanofian, she knows he will never settle. #IgnitingPotential #Paris2024 #WeNeverSettle Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024

🧠 Curious minds, get ready to expand your knowledge and address misconceptions. #NoJargon is back! This time, we asked our scientists to explain what a vaccine adjuvant is. Let's improve your scientific knowledge with Greg Troiano, Lorena Preciado Llanes and Vincent PAVOT 👇

“I’m happy to be in a place where people were ready to help me become the person I know I was always meant to be.” Jill Wuyts, production technician, was touched by the immediate support and kindness her co-workers showed to make her feel comfortable when she came out as a transgender woman. Our Sanofians do their best work chasing the miracles of science when they can be their authentic selves. We’re proud to be recognized by the Human Rights Campaign Foundation as a “Best Place to Work” for LGBTQ+ employees and take pride in the opportunities to learn from each other this #Pride month and all year long. Watch for more of Jill’s story ⤵️ #PursueProgress #PrideMonth

The Sanofi Cup Final was legendary! 🏆      Almost 300 Sanofi athletes from across the world. 24 teams. 5 sports. And as One Sanofi, we came together to channel the spirit of the Olympic and Paralympic Games Paris 2024: our determination and teamwork taking center stage 💪      We #NeverSettle: whether it comes to improving the lives of patients or competing in sports with our fellow colleagues, Sanofians know how to #IgnitePotential in themselves and others 🔥      #Paris2024 Paris 2024 - Comité d'organisation des Jeux Olympiques et Paralympiques de 2024    

We’re exploring areas of high unmet need in #MultipleMyeloma. Phase 3 data at #ASCO24 showcases the potential of our investigational therapy as a treatment option for people living with transplant-ineligible newly diagnosed multiple myeloma. Read our press release: http://spkl.io/60454fwYD

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval for our treatment for adults with uncontrolled chronic obstructive pulmonary disease (#COPD) with raised blood eosinophils. If approved, this medicine would be the first-ever targeted therapy for this disease and first new treatment approach in more than a decade. Read more about the news: https://lnkd.in/eQm69VPw Regeneron

We’re harnessing our deep expertise in immunology and scientific innovation in vaccines to build an #Immunoscience powerhouse. Our scientists believe we can help change not only how we understand the role of the immune system, but also how we can use it to treat and protect against more diseases than ever before. Read more about how Sanofi is redefining the next generation of therapeutic R&D with immunoscience: http://spkl.io/60454fyqF #Sanofi #WeNeverSettle

What does a typical day look like for our scientists? For Christophe Lechauve, it starts with coffee and ends with a family movie night. In between, he’s leading a team researching new treatments for rare blood disorders and liver diseases. Stay tuned for more #LittleMomentsFromTheLab from our scientists.

“Speak up and show what you can do.” For Monique V., Supply Chain Transformation Leader at Sanofi, diversity means everything. It helps us develop the best ideas across the organization, leading to the best solutions for patients. Listen to Monique’s story and learn how her background helps drive her work today. #PursueProgress #Science #Diversity

And that’s a wrap for #VivaTech Day 2! ✨ Today, we showcased how AI is transforming R&D at Sanofi with Houman Ashrafian, our Global Head of R&D - alongside inspiring talks covering our CodonBERT tool and clinical trial optimisation. Join us tomorrow on Stand J24 for more exciting pitchs from our experts and experience how Sanofi is putting #AI in the hands of all Sanofians. Emmanuel Frenehard Audrey Lhomme Fernando Ulloa Montoya Photography © Benoît RAJAU